Kraig Biocraft Laboratories (KBLB) Notes Payables (2016 - 2022)
Kraig Biocraft Laboratories (KBLB) has disclosed Notes Payables for 6 consecutive years, with $1.6 million as the latest value for Q3 2022.
- Quarterly Notes Payables rose 6.14% to $1.6 million in Q3 2022 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Sep 2022, up 6.14% year-over-year, with the annual reading at $503423.0 for FY2021, N/A changed from the prior year.
- Notes Payables hit $1.6 million in Q3 2022 for Kraig Biocraft Laboratories, up from $1.2 million in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $1.7 million in Q2 2021 to a low of $195000.0 in Q1 2018.
- Historically, Notes Payables has averaged $770143.1 across 4 years, with a median of $442000.0 in 2019.
- Biggest YoY gain for Notes Payables was 465.39% in 2022; the steepest drop was 26.06% in 2022.
- Year by year, Notes Payables stood at $322000.0 in 2018, then surged by 37.27% to $442000.0 in 2019, then grew by 13.9% to $503423.0 in 2021, then skyrocketed by 221.2% to $1.6 million in 2022.
- Business Quant data shows Notes Payables for KBLB at $1.6 million in Q3 2022, $1.2 million in Q2 2022, and $1.6 million in Q1 2022.